From January 1, 2022 to January 19, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,273,523 shares, representing 1.44% for CNY 79.31 million under the buyback announced on January 21, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.54 CNY | -0.43% |
|
-2.96% | -32.93% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.93% | 559M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- 603590 Stock
- News Beijing Konruns Pharmaceutical Co.,Ltd.
- Tranche Update on Beijing Konruns Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 21, 2021.